FDA NDC Directory · JSON-LD · Markdown

Eribulin Mesylate

NDC 68001-656 · HUMAN PRESCRIPTION DRUG · SOLUTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA214850
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsERIBULIN MESYLATE (.5 mg/mL)
Marketing started20251008
Package count1

External sources

Source: openFDA. Public-domain (CC0).